Verify a regenerative medicine treatment offer
Received a proposal from a clinic, coordinator or hospital in China? We review the provider, claimed status, treatment identity, documents and price structure before you commit.
Before paying a deposit or booking a flight.
Commercial treatment offers may use scientific terms, hospital names, trial registrations and patient testimonials. Those elements do not automatically prove that the proposed treatment is authorised, appropriate or supported for your condition.
- You received a high-value treatment quotation
- The provider claims government or hospital approval
- A trial number is used to sell a commercial package
- The cell source, manufacturing or medical team is unclear
- The offer promises broad benefits or a guaranteed outcome
- You want a second view before deciding
What we can review
The scope is agreed before we begin. Complex cases may require translation or direct provider clarification.
Provider identity
Hospital, company, department, doctor and the entity receiving payment.
Claimed status
Approval, clinical application, trial registration or research description.
Treatment identity
Cell source, autologous/allogeneic route, dose, administration and manufacturing.
Evidence claims
Whether cited studies apply to the same product, condition and outcome.
Quotation structure
Medical fees, deposits, inclusions, exclusions and coordination charges.
Red flags
Guarantees, pressure, missing consent, vague provider responsibility and unsafe claims.
A written verification summary
The report is practical rather than decorative. It is designed to support your next decision.
What appears verified
- Identifiable provider and responsible institution
- Traceable clinical or regulatory route
- Clear treatment identity and medical scope
- Relevant evidence or official sources
What remains unanswered
- Missing or contradictory approval claims
- Unclear foreign-patient eligibility
- Unsupported efficacy language
- Unitemised fees or problematic payment instructions
What verification does not do
It does not guarantee safety, efficacy, legal outcome, enrolment or medical eligibility. A qualified institution and treating physician remain responsible for the clinical decision and informed consent.
Frequently asked questions
Not always. We can first review documents and public claims. With your permission, direct clarification may be useful.
No one can determine that from marketing material. We assess the pathway, evidence, claimed status, provider and unanswered clinical questions.
Our primary expertise is China. We may identify general red flags elsewhere but cannot represent that we have verified another country’s law or provider network.
The fee depends on complexity, translation and whether direct institution contact is required. You receive the scope and price before work starts.
The quotation, treatment plan, provider name, doctor, claimed approval or registry number, proposed cell type and any consent documents.
We explain what is missing, what claims remain unsupported and which questions you should ask before making a decision.
Send us the offer before you commit.
Include the provider name, proposed treatment, quotation, claimed approval and any documents you received. We will define the verification scope and fee.